Company · CIK 0001041024 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ROCKWELL MEDICAL, INC. · RMTI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 6, 9:26 am EDT | Joseph H DawsonDirector | 9,633 | — | — | 12,133 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:26 am EDT | Allen NissensonDirector | 9,633 | — | — | 23,892 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:25 am EDT | Joan LauDirector | 9,633 | — | — | 20,944 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:25 am EDT | Robert S RadieDirector | 9,633 | — | — | 23,985 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:24 am EDT | John G CooperDirector | 9,633 | — | — | 23,670 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:24 am EDT | Timothy CholeSVP and CCO | 15,000 | — | — | 27,285 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:23 am EDT | Heather HunterChief Operating Officer | 15,000 | — | — | 28,007 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:22 am EDT | Megan C. TimminsEVP, CLO & Secretary | 15,000 | — | — | 31,240 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:21 am EDT | Jesse NeriSVP and CFO | 15,000 | — | — | 27,239 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 9:21 am EDT | Mark StrobeckPresident and CEO, Director | 30,000 | — | — | 62,349 | — | |
| Dec 21, 2018 JForm 4 → | Dec 27, 4:28 pm EST | Mark H RavichDirector | 66,600 | — | — | 336,950 | — | plan? late |
| Nov 28, 2018 AForm 4 → | Nov 29, 6:02 pm EST | Angus W. SmithChief Financial Officer | 166,667 | — | — | 166,667 | — | plan? |
| Oct 15, 2018 PForm 4 → | Oct 17, 5:27 pm EDT | David S. Richmond +710% Owner | 5,541,562 | — | — | 5,541,562 | — | plan? |
| Oct 7, 2018 AForm 4 → | Oct 12, 4:54 pm EDT | Ajay GuptaSr. VP & Chief Scientific Off. | 100,000 | — | — | 590,949 | — | plan? late |
| Sep 20, 2018 FMForm 4 → | Sep 24, 8:05 pm EDT | David KullPrincipal Accounting Officer | 9,130 | $3.60 | $32,879 | 3,270 | — | plan? |
| Sep 4, 2018 AForm 4 → | Sep 6, 3:59 pm EDT | Stuart M PaulChief Executive Officer, Director | 388,125 | — | — | 388,125 | — | plan? |
| Jun 27, 2018 PForm 4 → | Jul 3, 11:15 am EDT | David S. Richmond +610% Owner | 12,561 | $4.50 | $56,583 | 36,249 | +53.0% | plan? late |
| Dec 15, 2017 FMForm 4/A → | Dec 26, 5:29 pm EST | Robert L ChioiniChairman, President and CEO, Director | 495,076 | $6.55 | $3,242,502 | 2,549,907 | — | plan? |
| Dec 15, 2017 SForm 4 → | Dec 19, 6:32 pm EST | David S. Richmond +610% Owner | 36 | $6.53 | $235 | 176,376 | −0.02% | plan? |
| Dec 15, 2017 FMForm 4 → | Dec 19, 5:54 pm EST | Robert L ChioiniChairman, President and CEO, Director | 645,076 | $6.55 | $4,225,002 | 2,549,907 | — | plan? amended |
| Dec 15, 2017 FMForm 4 → | Dec 19, 5:53 pm EST | Patrick J BagleyDirector | 99,243 | $6.55 | $650,004 | 116,307 | — | plan? |
| Dec 15, 2017 FMForm 4 → | Dec 19, 5:51 pm EST | Thomas E KlemaVice President, CFO | 173,675 | $6.55 | $1,137,505 | 671,492 | — | plan? |
| Dec 15, 2017 FMForm 4 → | Dec 19, 5:48 pm EST | Ronald D BoydDirector | 49,622 | $6.55 | $325,005 | 42,678 | — | plan? |
| Aug 10, 2017 PForm 4 → | Aug 28, 5:20 pm EDT | David S. Richmond +610% Owner | 605 | $6.34 | $3,836 | 42,100 | +1.46% | plan? late |
| Jun 21, 2017 FForm 4 → | Jun 23, 4:58 pm EDT | Raymond Dennis PrattVP of Drug Development | 76,230 | $7.20 | $548,856 | 317,970 | — | plan? |
| Jun 21, 2017 FForm 4 → | Jun 23, 4:56 pm EDT | Ajay GuptaChief Scientific Officer | 69,218 | $7.20 | $498,370 | 490,949 | — | plan? |
| Jun 21, 2017 FForm 4 → | Jun 23, 4:55 pm EDT | Thomas E KlemaVice President, CFO | 53,273 | $7.20 | $383,566 | 670,167 | — | plan? |
| Jun 21, 2017 FForm 4 → | Jun 23, 4:54 pm EDT | Robert L ChioiniChairman, President and CEO, Director | 118,950 | $7.20 | $856,440 | 2,544,983 | — | plan? |
| May 19, 2017 XForm 4 → | May 23, 5:50 pm EDT | Mark H Ravich +4Other | 40,000 | $6.00 | $240,000 | 10,000 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:44 pm EDT | Patrick J BagleyDirector | 9,800 | — | — | 115,550 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:43 pm EDT | Ronald D BoydDirector | 9,800 | — | — | 42,300 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:42 pm EDT | Robin L SmithDirector | 9,800 | — | — | 9,800 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:41 pm EDT | Raymond Dennis PrattVP of Drug Development | 68,500 | — | — | 394,200 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:40 pm EDT | Ajay GuptaChief Scientific Officer | 68,500 | — | — | 560,167 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:40 pm EDT | Robert L ChioiniChairman, President and CEO, Director | 245,000 | — | — | 2,663,933 | — | plan? |
| Mar 21, 2017 AForm 4 → | Mar 23, 6:38 pm EDT | Thomas E KlemaVice President, CFO | 68,600 | — | — | 723,440 | — | plan? |
| Mar 21, 2017 PForm 4 → | Mar 23, 5:24 pm EDT | David S. Richmond +610% Owner | 37,210 | $5.84 | $217,492 | 29,802 | — | plan? |
| Mar 16, 2017 SForm 4 → | Mar 20, 5:46 pm EDT | Kenneth L HoltDirector | 6,000 | $5.98 | $35,871 | 12,630 | −32.2% | plan? |
| Nov 9, 2016 SForm 4 → | Nov 14, 6:11 pm EST | Kenneth L HoltDirector | 19,725 | $5.16 | $101,687 | 18,630 | −51.4% | plan? late |
| Nov 1, 2016 SForm 4 → | Nov 3, 5:37 pm EDT | Kenneth L HoltDirector | 1,400 | $5.92 | $8,288 | 38,355 | −3.52% | plan? |
| Oct 19, 2016 SForm 4 → | Oct 21, 5:15 pm EDT | Kenneth L HoltDirector | 2,533 | $6.04 | $15,299 | 39,755 | −5.99% | plan? |
| Sep 16, 2016 SForm 4 → | Sep 20, 5:13 pm EDT | Kenneth L HoltDirector | 8,075 | $6.81 | $54,977 | 42,288 | −16.0% | plan? |
| Aug 12, 2016 SForm 4 → | Aug 16, 5:00 pm EDT | Kenneth L HoltDirector | 3,692 | $7.31 | $26,991 | 59,883 | −5.81% | plan? |
| Feb 9, 2016 SForm 4 → | Aug 26, 5:15 pm EDT | Kenneth L HoltDirector | 9,520 | $6.37 | $60,656 | 50,363 | −15.9% | plan? late |
| Jan 15, 2016 MForm 4 → | Jan 19, 5:21 pm EST | Kenneth L HoltDirector | 25,000 | $3.09 | $77,250 | 63,575 | — | plan? |
| Dec 15, 2015 FMForm 4 → | Dec 17, 6:31 pm EST | Thomas E KlemaVice President, CFO | 155,000 | $6.96 | $1,078,875 | 677,240 | — | plan? |
| Dec 11, 2015 FMForm 4 → | Dec 15, 5:13 pm EST | Robert L ChioiniChairman, President and CEO, Director | 450,000 | $5.35 | $2,406,000 | 2,418,933 | — | plan? |
| Dec 11, 2015 MForm 4 → | Dec 15, 5:10 pm EST | Patrick J BagleyDirector | 25,000 | $4.55 | $113,750 | 105,750 | — | plan? |
| Dec 4, 2015 SForm 4 → | Dec 8, 5:06 pm EST | Ronald D BoydDirector | 12,500 | $10.58 | $132,273 | 32,500 | −27.8% | plan? |
| Dec 4, 2015 MForm 4 → | Dec 8, 5:06 pm EST | Ronald D BoydDirector | 12,500 | $4.55 | $56,875 | 45,000 | — | plan? |
| Nov 11, 2015 MForm 4 → | Nov 13, 5:11 pm EST | Kenneth L HoltDirector | 25,000 | $4.55 | $113,750 | 38,575 | — | plan? |
| Oct 2, 2015 AForm 4 → | Oct 7, 8:57 pm EDT | Patrick J BagleyDirector | 15,000 | — | — | 80,750 | — | plan? late |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:58 pm EDT | Ronald D BoydDirector | 15,000 | — | — | 32,500 | — | plan? |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:51 pm EDT | Thomas E KlemaVice President, CFO | 150,000 | — | — | 644,740 | — | plan? |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:39 pm EDT | Robert L ChioiniChairman, President and CEO, Director | 325,000 | — | — | 2,118,933 | — | plan? |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:38 pm EDT | Ajay GuptaChief Scientific Officer | 165,000 | — | — | 491,667 | — | plan? |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:37 pm EDT | Raymond Dennis PrattVP of Drug Development | 165,000 | — | — | 325,700 | — | plan? |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:36 pm EDT | Kenneth L HoltDirector | 15,000 | — | — | 36,509 | — | plan? |
| Aug 14, 2015 PForm 4 → | Aug 14, 3:56 pm EDT | Robert L ChioiniChairman, President and CEO, Director | 4,910 | $11.96 | $58,724 | 1,793,933 | +0.27% | plan? |
| Aug 13, 2015 PForm 4 → | Aug 14, 9:33 am EDT | Ajay GuptaChief Scientific Officer | 5,000 | $11.62 | $58,112 | 326,667 | +1.55% | plan? |
| Aug 13, 2015 PForm 4 → | Aug 14, 9:30 am EDT | Raymond Dennis PrattVP of Drug Development | 5,000 | $11.54 | $57,675 | 160,700 | +3.21% | plan? |
| Aug 13, 2015 PForm 4 → | Aug 14, 9:29 am EDT | Robert L ChioiniChairman, President and CEO, Director | 5,090 | $11.51 | $58,598 | 1,789,023 | +0.29% | plan? |
| Jun 12, 2015 GForm 4 → | Aug 14, 9:33 am EDT | Ajay GuptaChief Scientific Officer | 25,000 | — | — | 321,667 | — | plan? late |
| May 1, 2015 FForm 4 → | May 5, 5:17 pm EDT | Raymond Dennis PrattVP of Drug Development | 34,650 | $9.64 | $334,026 | 155,700 | — | plan? |
| May 1, 2015 FForm 4 → | May 5, 5:04 pm EDT | Thomas E KlemaVice President, CFO | 27,440 | $9.64 | $264,522 | 494,740 | — | plan? |
| May 1, 2015 FForm 4 → | May 5, 4:54 pm EDT | Ajay GuptaChief Scientific Officer | 15,048 | $9.64 | $145,063 | 346,667 | — | plan? |
| May 1, 2015 FForm 4 → | May 5, 4:46 pm EDT | Robert L ChioiniChairman, President and CEO, Director | 73,200 | $9.64 | $705,648 | 1,783,933 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 3, 5:01 pm EST | Raymond Dennis PrattVP of Drug Development | 34,650 | $10.47 | $362,786 | 190,350 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 3, 5:00 pm EST | Thomas E KlemaVice President, CFO | 27,440 | $10.47 | $287,297 | 522,180 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 3, 4:59 pm EST | Ajay GuptaChief Scientific Officer | 31,500 | $10.47 | $329,805 | 361,715 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 3, 4:58 pm EST | Robert L ChioiniChairman, President and CEO, Director | 46,200 | $10.47 | $483,714 | 1,857,133 | — | plan? |
| Dec 18, 2014 MForm 4/A → | Oct 7, 2015, 8:52 pm EDT | Ronald D BoydDirector | 12,500 | $2.79 | $34,875 | 17,500 | — | plan? |
| Jul 13, 2013 SForm 4 → | Nov 13, 2015, 5:08 pm EST | Kenneth L HoltDirector | 7,934 | $8.85 | $70,243 | 13,575 | −36.9% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2018 AForm 4 → | Nov 29, 6:02 pm EST | Angus W. SmithChief Financial Officer | 333,333 | — | — | 333,333 | — | |
| Oct 15, 2018 PForm 4 → | Oct 17, 5:27 pm EDT | David S. Richmond +710% Owner | 5,541,562 | — | — | 5,541,562 | — | |
| Sep 20, 2018 MForm 4 → | Sep 24, 8:05 pm EDT | David KullPrincipal Accounting Officer | 5,000 | — | — | 0 | — | |
| Sep 4, 2018 AForm 4 → | Sep 6, 3:59 pm EDT | Stuart M PaulChief Executive Officer, Director | 388,125 | — | — | 388,125 | — | |
| Aug 24, 2018 AForm 4 → | Sep 24, 8:00 pm EDT | David KullPrincipal Accounting Officer | 25,000 | — | — | 25,000 | — | late |
| Mar 19, 2018 AForm 4 → | Mar 21, 6:10 pm EDT | Benjamin WolinDirector | 52,501 | — | — | 52,501 | — | |
| Mar 19, 2018 AForm 4 → | Mar 21, 6:09 pm EDT | Mark H RavichDirector | 38,416 | — | — | 38,416 | — | |
| Mar 19, 2018 AForm 4 → | Mar 21, 6:07 pm EDT | Robin L SmithDirector | 38,985 | — | — | 38,985 | — | |
| Mar 19, 2018 AForm 4 → | Mar 21, 5:57 pm EDT | John G CooperDirector | 39,838 | — | — | 39,838 | — | |
| Mar 19, 2018 AForm 4 → | Mar 21, 5:56 pm EDT | Lisa N ColleranDirector | 36,281 | — | — | 36,281 | — | |
| Mar 19, 2018 AForm 4 → | Mar 21, 5:55 pm EDT | Ronald D BoydDirector | 36,139 | — | — | 36,139 | — | |
| Mar 19, 2018 AForm 4 → | Mar 21, 5:54 pm EDT | Patrick J BagleyDirector | 32,724 | — | — | 32,724 | — | |
| Dec 15, 2017 MForm 4/A → | Dec 26, 5:29 pm EST | Robert L ChioiniChairman, President and CEO, Director | 250,000 | — | — | 0 | — | |
| Dec 15, 2017 MForm 4 → | Dec 19, 5:54 pm EST | Robert L ChioiniChairman, President and CEO, Director | 325,000 | — | — | 0 | — | amended |
| Dec 15, 2017 MForm 4 → | Dec 19, 5:53 pm EST | Patrick J BagleyDirector | 50,000 | — | — | 0 | — | |
| Dec 15, 2017 MForm 4 → | Dec 19, 5:51 pm EST | Thomas E KlemaVice President, CFO | 87,500 | — | — | 0 | — | |
| Dec 15, 2017 MForm 4 → | Dec 19, 5:48 pm EST | Ronald D BoydDirector | 25,000 | — | — | 0 | — | |
| Sep 5, 2017 AForm 4 → | Sep 8, 6:36 pm EDT | John G CooperDirector | 23,000 | — | — | 23,000 | — | late |
| May 19, 2017 XForm 4 → | May 23, 5:50 pm EDT | Mark H Ravich +4Other | 400 | — | — | 0 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 6:31 pm EDT | Robin L SmithDirector | 25,000 | — | — | 25,000 | — | |
| Jan 15, 2016 MForm 4 → | Jan 19, 5:21 pm EST | Kenneth L HoltDirector | 25,000 | — | — | 0 | — | |
| Dec 15, 2015 MForm 4 → | Dec 17, 6:31 pm EST | Thomas E KlemaVice President, CFO | 93,750 | — | — | 0 | — | |
| Dec 11, 2015 MForm 4 → | Dec 15, 5:13 pm EST | Robert L ChioiniChairman, President and CEO, Director | 375,000 | — | — | 0 | — | |
| Dec 11, 2015 MForm 4 → | Dec 15, 5:10 pm EST | Patrick J BagleyDirector | 25,000 | — | — | 0 | — | |
| Dec 4, 2015 MForm 4 → | Dec 8, 5:06 pm EST | Ronald D BoydDirector | 12,500 | — | — | 0 | — | |
| Nov 11, 2015 MForm 4 → | Nov 13, 5:11 pm EST | Kenneth L HoltDirector | 25,000 | — | — | 0 | — | |
| Oct 2, 2015 AForm 4 → | Oct 7, 8:57 pm EDT | Patrick J BagleyDirector | 35,000 | — | — | 35,000 | — | late |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:58 pm EDT | Ronald D BoydDirector | 35,000 | — | — | 35,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:51 pm EDT | Thomas E KlemaVice President, CFO | 215,000 | — | — | 215,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:39 pm EDT | Robert L ChioiniChairman, President and CEO, Director | 775,000 | — | — | 275,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:38 pm EDT | Ajay GuptaChief Scientific Officer | 215,000 | — | — | 215,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:37 pm EDT | Raymond Dennis PrattVP of Drug Development | 215,000 | — | — | 215,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 9:36 pm EDT | Kenneth L HoltDirector | 35,000 | — | — | 35,000 | — |